Amerisource deal may not keep Walgreens competitive: analysts

(Reuters) - Walgreens’ potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative specialty pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, analysts said. A deal would not be a surprise, but analysts noted that it might cost Walgreens Boots Alliance opportunities down the line as the company trie...